Get a free sample of Cystatin C Assay Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Get a free sample of Cystatin C Assay Market
Thank you!
Your inquiry has been received. Our team will reach out to you with the required details via email. To ensure that you don't miss their response, kindly remember to check your spam folder as well!
Form submitted successfully!
Error submitting form. Please try again.
Cystatin C Assay Market Size
Cystatin C Assay Market was valued at USD 269.6 million in 2023 and is anticipated to grow at a CAGR of over 7.7% between 2024 & 2032. A cystatin C assay is a laboratory test designed to measure the concentration of cystatin C in biological samples, typically in blood or serum. It is commonly used as a biomarker for estimating glomerular filtration rate (GFR). The assays play a vital role in the early diagnosis, monitoring, and kidney stone management, contributing to improved patient outcomes and driving innovation in the field of renal function assessment.
The increasing prevalence of chronic kidney diseases is anticipated to augment the cystatin C assay market. According to the report published by the Centers for Disease Control and Prevention (CDC) in 2022, more than 1 in 7 U.S. adults, about 14% or an estimated 37 million people are affected by CKD. Thus, as the incidence of chronic kidney diseases increases globally the demand for effective diagnostic solutions to measure the concentration of cystatin C, stimulating market growth.
How big is the cystatin C assay industry?
Market size for cystatin C assay was USD 269.6 million in 2023 and is expected to reach USD 522.6 billion by 2032 due to the increasing prevalence of chronic kidney diseases and in the surging need for early diagnosis, monitoring, and kidney stone management worldwide.
Why is the cystatin C assay market growing from kit products?
Cystatin C assay industry size from the kits products segment recorded USD 116.8 million in 2023 and is expected to register an appreciable CAGR from 2024-2032 owing to their prominent role in providing laboratories and healthcare facilities with convenient and ready-to-use solutions.
What factors are influencing cystatin C assay market growth from the U.S.?
U.S. industry size for cystatin C assay recorded USD 102.4 million in 2023 due to the advanced healthcare infrastructure, widespread access to cutting-edge diagnostic technologies, and the increasing prevalence of chronic kidney diseases in the region.
Who are the key cystatin C assay business players?
Siemens Healthineers AG, Abbott Laboratories, Beckman Coulter (Danaher Corporation), Thermo Fisher Scientific Inc, bioM